RateCaptain
  • Home
    • About Us
    • Contact Us
  • FX Rates
  • Money Market
  • Cryptocurrency
  • Commodities
  • Corporates
No Result
View All Result
Subscribe
  • Home
    • About Us
    • Contact Us
  • FX Rates
  • Money Market
  • Cryptocurrency
  • Commodities
  • Corporates
No Result
View All Result
RateCaptain
No Result
View All Result
Home Business

India to Resume Covid Vaccine Exports in 2022

Rate Captain by Rate Captain
August 24, 2021
in Business, Health
Reading Time: 3 mins read
A A
0
Share on FacebookShare on TwitterShare on WhatsappShare on Telegram

India will likely restart exporting Covid-19 vaccines next year once it has immunized its own adult population, the head of an influential government expert panel said.

AlsoRead

Dangote Refinery Shares Could Start Trading on December 8 After ₦2.15 Trillion IPO

Securities Auctions Plunge 55.86% to ₦9.50 Trillion in October as Bond Yields Rise

Court Hits 21 Unlicensed Investment Firms with N30 Million Fines Each

“Almost 60 countries are hardly having any access to vaccine and India should be able to provide a substantial portion in 2022,” N.K. Arora, chairman of the National Technical Advisory Group on Immunization in India, said in an interview with Bloomberg Television on Tuesday. “As soon as we are through with our adult population we should have sufficient vaccine to share with the rest of the world.”

The South Asian nation, which has the second largest Covid outbreak with 32.5 million infections, should have six locally-developed shots by the end of 2021, Arora said. As the head of vaccine advisory group, he helps the Indian federal government evaluate new vaccines as well as review data from those already rolled out.

Home to the world’s biggest vaccine-producing industry, India earlier this year was shipping out shots to poorer nations amid Prime Minister Narendra Modi’s much-touted vaccine diplomacy. There was also an expectation that the country would be a major supplier to the World Health Organization-backed Covax effort for global equitable access to these vaccines.

But the onset of a devastating second-wave of infections and local supply delays prompted the government to prioritize its own citizens and halted overseas shipments in April.

Covax has since struggled to make up for the shortfall, looking instead to countries such as China to fill the gap as India slowly bolsters its own capacity. A boosted portfolio of vaccines by the year end should cover Indian government’s plans to fully immunize 920 million adults, Arora said.

India Approves DNA-based Covid Shot, Boosting Vaccine Plan

“That means our requirement will be 1.8 million doses by that time,” he said. “The way our pipeline is we should be able to reach and meet our target by the end of the year.”

Upcoming Production

Already vaccines from AstraZeneca Plc — churned out by the Serum Institute of India Ltd. — and Bharat Biotech International Ltd. are being widely deployed in the country, while doses from Cadila Healthcare Ltd. and Russia’s Sputnik V are expected to begin local production in coming months.

Serum, the country’s largest supplier, should be raising its monthly contribution to about 150 million doses from almost 120 million shots currently, Arora said. By September, Bharat Biotech will provide about 120 million doses after “some initial glitches.” Other Indian vaccine makers, Biological E. Ltd. and Genova Biopharmaceuticals Ltd., should also start contributing to the supplies, he said.

India has so far administered more than 589 million doses, but even that huge coverage has only fully vaccinated about 10% of the population, according to Bloomberg’s vaccine tracker.

Arora said that India isn’t looking to imported vaccines to help boost its own supplies. The country has been negotiating with foreign vaccine makers, such as Pfizer Inc., over legal indemnity clauses that the companies are demanding but there’s been no breakthrough yet.

“We are totally, kind of, banking on indigenously manufactured vaccines,” he said. “Our estimates on supply lines do not take into account any of the vaccines from abroad.”

Previous Post

Buhari’s Medical Trips And Nigeria’s Decaying Health Sector

Next Post

Governor Makinde “Join Politics If You Want Nigeria To Progress”

Related News

Oil Marketers Dismiss Claims of Dangote Refinery Selling Fuel in Dollars

Dangote Refinery Shares Could Start Trading on December 8 After ₦2.15 Trillion IPO

by Akpan Edidong
November 5, 2026
0

Shares in Dangote Petroleum Refinery and Petrochemicals may begin trading on the Nigerian Exchange from 8 December 2026, after the...

Nigeria’s Stock Market Records N1.81 Trillion Gain in July.

Securities Auctions Plunge 55.86% to ₦9.50 Trillion in October as Bond Yields Rise

by Victoria Attah
November 4, 2026
0

Allotments at Nigeria’s government securities auctions fell sharply in October 2026, dropping 55.86% to ₦9.501 trillion from ₦21.527 trillion in...

NGX Fines Banks N76.8 Million for Late Financial Reporting

Court Hits 21 Unlicensed Investment Firms with N30 Million Fines Each

by Victoria Attah
September 29, 2026
0

Nigeria’s capital market regulators have scored a significant enforcement win after a Federal High Court in Nasarawa State convicted 21...

Nigeria’s Stock Market Records N1.81 Trillion Gain in July.

Sterling, AIICO and Fidelity Lead Volumes as NGX Gains About N315 Billion

by Jide Omodele
September 17, 2026
0

The Nigerian Exchange recorded turnover of 662.35 million shares on Wednesday, 16 September 2026, as investors kept up strong activity...

Next Post

Governor Makinde "Join Politics If You Want Nigeria To Progress"

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recommended

Nigeria Customs Service Modernisation Project Aims to Generate $200bn in Revenue

Customs Plans B’Odogwu Upgrade to Speed Cargo Clearance and Tighten Transit Tracking

November 19, 2026
Investment Bankers Applaud CBN Reforms Amidst Challenges, Embrace Growth Opportunities

Fitch Sees Nigeria’s Policy Rate Averaging 18.6% by 2028 as Inflation Eases

November 19, 2026

Popular Story

  • kms tools office 2024 ✓ Activate Microsoft Office Easily ➔ Step-by-Step Guide

    0 shares
    Share 0 Tweet 0
  • Shocking: “Undress” An AI Tool That Unveils Digital Representations of Individuals Without Clothing

    0 shares
    Share 0 Tweet 0
  • Nigeria Adopts World Bank’s Blockchain Platform FundsChain to Track Donor Projects

    0 shares
    Share 0 Tweet 0
  • GTBank Raises Naira Card International Spending Limit to $40,000

    0 shares
    Share 0 Tweet 0
  • Access Holdings Weighs Foreign Exit as CBN’s 10% Overseas Cap Forces Hard Choices

    0 shares
    Share 0 Tweet 0

RateCaptain

We bring you the most accurate in new and market data. Check our landing page for details.

  • Home
  • About Us
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
  • Cookie Policy
  • Contact Us

Copyright © 2022 RateCaptain - All rights reserved by RateCaptain.

No Result
View All Result
  • Home
    • About Us
    • Contact Us
  • FX Rates
  • Money Market
  • Cryptocurrency
  • Commodities
  • Corporates

Copyright © 2022 RateCaptain - All rights reserved by RateCaptain.

RateCaptain
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}
?>